FLG, FLG2, RPTN and SPRR1A together might be considered potential candidate biomarkers for differential diagnosis in AD and CTCL using either PCR or ELISA method. This evidence concerns the gene SPRR1A and primary cutaneous T-cell non-Hodgkin lymphoma.